These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29748932)

  • 1. Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial.
    van Rongen A; van der Aa MP; Matic M; van Schaik RHN; Deneer VHM; van der Vorst MM; Knibbe CAJ
    Paediatr Drugs; 2018 Aug; 20(4):365-374. PubMed ID: 29748932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
    van Rongen A; Vaughns JD; Moorthy GS; Barrett JS; Knibbe CA; van den Anker JN
    Br J Clin Pharmacol; 2015 Nov; 80(5):1185-96. PubMed ID: 26044579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.
    van Rongen A; Brill MJE; Vaughns JD; Välitalo PAJ; van Dongen EPA; van Ramshorst B; Barrett JS; van den Anker JN; Knibbe CAJ
    Clin Pharmacokinet; 2018 May; 57(5):601-611. PubMed ID: 28785981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.
    van der Aa MP; Elst MA; van Mil EG; Knibbe CA; van der Vorst MM
    Trials; 2014 Jun; 15():207. PubMed ID: 24899137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-551. PubMed ID: 28258392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.
    Sam WJ; Roza O; Hon YY; Alfaro RM; Calis KA; Reynolds JC; Yanovski JA
    J Clin Pharmacol; 2017 Feb; 57(2):219-229. PubMed ID: 27407018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
    Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
    JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents.
    Zhang T; Smit C; Sherwin CMT; Knibbe CAJ; Krekels EHJ
    Clin Pharmacokinet; 2023 May; 62(5):749-759. PubMed ID: 37017883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis.
    Hui F; Zhang Y; Ren T; Li X; Zhao M; Zhao Q
    Eur J Clin Pharmacol; 2019 Apr; 75(4):437-450. PubMed ID: 30511328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.
    van der Aa MP; Hoving V; van de Garde EM; de Boer A; Knibbe CA; van der Vorst MM
    J Obes; 2016; 2016():7852648. PubMed ID: 28101379
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR; Dhakal-Karki S; Dunican KC
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M; Alibrandi A; Giarrusso R; Lo Monaco I; Muraca U
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis.
    Bouza C; López-Cuadrado T; Gutierrez-Torres LF; Amate J
    Obes Facts; 2012; 5(5):753-65. PubMed ID: 23108505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.